NCT04440189: An ongoing trial by GID BIO, Inc.
This trial is ongoing. It must report results 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04440189 |
|---|---|
| Title | Use of GID SVF-2 Device to Produce Autologous Adipose-Derived Stromal Vascular Fraction for Treatment of Osteoarthritis of the Knee: A Pivotal Medical Device Randomized Concurrent Controlled Study |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 15, 2020 |
| Completion date | Dec. 30, 2024 |
| Required reporting date | Dec. 30, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |